17 October, 2024Noema Pharma Announces NOE-105 (gemlapodect) Phase 2a Study in Tourette Syndrome met Primary and all Key Secondary Endpoints
15 October, 2024Bio-engineering scale-up Qorium showcases cultivated leather breakthrough, signalling a key step towards commercialisation
14 October, 2024Inventiva announces financing of up to €348 million to advance the NATiV3 Phase 3 MASH study
9 October, 2024Purespring Therapeutics raises £80/$105 million in a Series B financing to transform the treatment of kidney diseases
25 September, 2024Genespire raises €46.6 million (~$52 million) in a Series B round to advance its first pediatric in-vivo gene therapy into the clinic